Activation of the mTOR pathway as a potential therapeutic target in muscle-invasive urothelial carcinoma

被引：0
|
作者：
Hansel, Donna
Orloff, Mohammed
Harwalker, Jyoti
Platt, Eric
Sethu, Swathi
Hicks, Jessica
De Marzo, Angelo
Steinle, Roxanne
Hsi, Eric
Eng, Charis
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2744
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder
    Mossanen, Matthew
    Lee, Franklin
    Cheng, Heather
    Harris, William
    Shenoi, Jaideep
    Zhao, Song
    Wang, Junfeng
    Champion, Thomas
    Izard, Jason
    Gore, John L.
    Porter, Michael P.
    Yu, Evan Y.
    Wright, Jonathan L.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (03) : 210 - 213
  • [32] THE MTOR SIGNALING PATHWAY AS POTENTIAL THERAPEUTIC TARGET IN MENINGIOMAS
    Mawrin, C.
    Andrae, N.
    Kirches, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 43 - 44
  • [33] The mTOR signaling pathway as potential therapeutic target in meningiomas
    Mawrin, C.
    Andrae, N.
    Kirches, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S97 - S97
  • [34] mTOR pathway as a potential therapeutic target for cancer stem cells in canine mammary carcinoma
    Michishita, Masaki
    Ochiai, Kazuhiko
    Nakahira, Rei
    Azakami, Daigo
    Machida, Yukino
    Nagashima, Tomokazu
    Nakagawa, Takayuki
    Ishiwata, Toshiyuki
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] mTOR Pathway Activation in pT1 Urothelial Cell Carcinomas of the Bladder: A Potential Target of Therapy
    Cox, R.
    Chaux, A.
    Solus, J.
    Schultz, L.
    Demarzo, A.
    Comperat, E.
    Netto, G. J.
    LABORATORY INVESTIGATION, 2011, 91 : 186A - 186A
  • [36] Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder
    Softness, Kenneth
    Kaul, Sumedh
    Fleishman, Aaron
    Efstathiou, Jason
    Bellmunt, Joaquim
    Kim, Simon P.
    Korets, Ruslan
    Chang, Peter
    Wagner, Andrew
    Olumi, Aria F.
    Gershman, Boris
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (06) : 272.e1 - 272.e9
  • [37] Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma
    Achkar, Tala
    Parikh, Rahul A.
    UROLOGIC CLINICS OF NORTH AMERICA, 2018, 45 (02) : 257 - +
  • [38] Avelumab as neoadjuvant therapy in subjects with muscle-invasive urothelial carcinoma (AURA trial).
    Chanza, Nieves Martinez
    Roumeguere, Thierry Andre
    Sideris, Spyridon
    Gil, Thierry
    Peltier, Alexandre
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [39] Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs
    Shingo Maeda
    Kosei Sakai
    Kenjiro Kaji
    Aki Iio
    Maho Nakazawa
    Tomoki Motegi
    Tomohiro Yonezawa
    Yasuyuki Momoi
    Scientific Reports, 12
  • [40] Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder
    Hensley, Patrick J.
    Goodwin, Jeffrey
    Davenport, Daniel L.
    Strup, Stephen E.
    James, Andrew
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E851 - E858
12345